Could a wearable device prevent dangerous blood sugar swings in hospital patients?
NCT ID NCT04230694
First seen May 01, 2026 · Last updated Jun 22, 2026 · Updated 8 times
Summary
This pilot study tested a continuous glucose monitor (CGM) in 40 hospitalized adults with type 1 or type 2 diabetes. The goal was to see if using the device could help detect and reduce episodes of low and high blood sugar. Researchers compared CGM readings to standard care to gather evidence for wider hospital use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor Scott & White Medical Center - Temple
Temple, Texas, 76508, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom Generation 6 CGM device
What this could lead to
If successful, this could show that continuous glucose monitoring is a practical and effective way to manage blood sugar in hospitalized patients with diabetes.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply to all patients. The device may not be accurate in all hospital settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.